Intraperitoneal (i.p.) immunization with herpes simplex virus type 1 (HSV-1) or an anti-idiotypic antibody (anti-id C) prepared against a monoclonal antibody specific for glycoprotein C of HSV-1, tolerizes mice for an HSV-I delayed type hypersensitivity (DTH) response. This tolerization could be adoptively transferred to naive Xirradiated mice by splenic T cells, and was specific for HSV-1 DTH. Thus, DTHtolerized mice responded to vaccinia virus or HSV-2 challenge, while remaining tolerized for HSV-1 DTH. In addition, these animals demonstrated a form of split tolerance such that HSV antibody, cytotoxic T cell and lymphoproliferative responses were detected in vitro. Thus, anti-id C induced a T cell population capable of specifically suppressing the HSV-1 DTH response, mimicking the effect of i.p. and intravenous immunization with HSV-1 found previously.
INTRODUCTION
The ability of anti-idiotypic (anti-id) antisera to induce positive and immunoregulatory aspects of the immune response has been well documented, particularly in hapten systems (Sacks et al., 1983; Kennedy & Dreesman, 1985) . Since anti-ids may mimic antigenic epitopes, they represent an alternative to traditional vaccines and their use has been advocated against certain viruses (Dreesman & Kennedy, 1985; Koprowski, 1985) . Nevertheless, despite some encouraging observations, no anti-id can yet be considered as an acceptable antiviral vaccine.
In some instances, recipients of anti-id vaccines have become more susceptible to infection following immunization (Kennedy et al., 1984a) . This effect could result from the induction of an immunoregulatory suppressor circuit that impedes immunity. Precedence for this notion comes from hapten systems where exposure of mice to certain anti-id antibodies induces suppressor cells that inhibit aspects of immunity such as the delayed type hypersensitivity (DTH) response (Sy et al., 1979; Thomas et al., 1983) .
Recently, we have reported on the binding characteristics in vitro of two heterologous anti-id antibodies produced against monoclonal antibodies to herpes simplex virus type 1 (HSV-1) glycoproteins (Lathey et al., 1986 (Lathey et al., , 1987 . However, mice immunized with these reagents failed to mount more than minimal anti-HSV responses (Lathey et al., 1986 (Lathey et al., , 1987 . Furthermore, as is reported in the present communication, one of the anti-id reagents effectively activated an immunoregulatory suppressor cell(s) that selectively prevented a DTH response to HSV-1. The response was antigen-specific, long lasting, mediated by T cells and was adoptively transferrable. The effect appears to be identical to the split tolerance that occurs in mice following intraperitoneal (i.p) or intravenous (i.v.) exposure of mice to HSV-1 (Larsen et al., 1984; Nash, 1985) . The implications of our observations to the possible manipulation of immunopathology are discussed. 
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METHODS
Anti-idiotypic antibodies. The production and characterization of the anti-id antibodies have been described previously (Lathey et al., 1986 (Lathey et al., , 1987 . Briefly, rabbits were immunized with Protein A-purified monoclonal antibodies specific for glycoprotein C (gC) or glycoprotein D (gD) of HSV-1, producing anti-id C and anti-id D, respectively. Activity against allotypic determinants was removed by absorption with normal mouse immunoglobulin, Each anti-id was next adsorbed to and eluted from an affinity column bound with the immunizing monoclonal antibody. Anti-id C recognized a cross-reactive idiotope found on three HSV-specific monoclonal antibodies and interfered with the binding of each to its complementary protein epitope (Lathey et al., 1987) . Conversely, anti-id D was specific for the anti-gD immunogen and could inhibit the binding of anti-gD to gD (Lathey et al., 1986) . Table 1 summarizes these data.
Viruses. The KOS strain of HSV-1, the 186 strain of HSV-2 and the WR strain of vaccinia virus were used throughout these studies, The production and titration of the HSV stocks have been previously described (Eberle & Courtney, 1980) . The vaccinia virus was purified from the cytoplasm of infected HEp-2 cells as described previously (Joklik, 1962) . Ultraviolet light-inactivated virus was prepared by exposing 0-5 ml of virus stock to a germicidal lamp at a distance of 3 cm for 2 min. This reduced infectivity titres from 108 to 10 p.f.u./ml. reactions which were T cell-independent (data not shown) and those of 24h and after, DTH. Data are reported as mean differences in footpad swelling between the virus-challenged footpad and the saline-challenged footpad. Specific details of each experiment are included in figure legends.
Adoptive transfer. Donor mice tolerized for HSV-1, or control mice, were bled from the retro-orbital sinus, sacrificed and their spleens removed. Spleen cells, processed by the procedure of Lawman et al. (1980) , were diluted in saline to 6 x 107 cells/ml and transferred i.v., 0.5 ml per mouse. Recipient mice were X-irradiated (150 rad) immediately before i.v. injection of donor cells. Twenty-four h after transfer, recipient mice were primed in the left pinna (s.c.) with 4 x 106 p.f.u, of infectious HSV-1. The first hypersensitivity challenge was performed 14 days later. Spleen cells used in the cell depletion assay were treated with antibody plus complement (C') to remove specific cell populations before adoptive transfer. Antibody treatment was accomplished by incubating spleen cells with a pre-titrated amount of monoclonal anti-mouse Thy 1.2 (a gift from Dr Mark I. Green, Tufts University, Boston, Mass., U.S.A.) or goat anti-mouse immunoglobulins (IgA + IgG + IgM) (Cappel Laboratories) at 4 °C for 1 h. The cells were then washed and Low-Tox-M rabbit C' (Accurate Chemical and Scientific Corp., Westbury, N.Y., U.S.A.) was added for l h at 37 °C. After C' treatment, the ceils were washed and injected. Each mouse received 0.9 of a spleen equivalent determined before antibody treatment and C' depletion.
ELISA. The ELISA using infected cell extracts was performed as previously described (Lathey et al., 1987) . Lymphocyte assays. Mice which were the recipients of spleen cells from preimmune IgG, anti-id C, HSV-1 i.p. immunized mice or normal mice were given 4 × 106 p.f.u, of HSV-I in each pinna (10 gl) 24 h after adoptive transfer. One week later, footpad testing for DTH was performed. One month following DTH priming, the spleens were removed for lymphocyte assays. For the cytotoxic T cell (CTL) assay, spleen cells processed as described by Lawman et al. (1980) were incubated with u.v.-inactivated HSV-I (m.o.i. 2) in a small volume for 15 min at 37 °C. After enumeration, 5 x 105 cells were mixed with 5 x 10 s viral stimulator cells for 5 days. Culture was performed in U-bottomed 96-well microtitre plates in 200 ~tl of RPMI 1640, 10~ heat-inactivated foetal calf serum, 2 mI~-glutamine, penicillin (100 units/ml), streptomycin (100 gg/ml), gentamicin (50 gg/ml), and 5 x 10 -s mM-2-mercaptoethanol. Before the 4 h CTL assay on day 5, cells were washed once with PBS. The CTL assay was performed as described previously (Horohov et al., 1985) . Specific release was determined by the following formula: [(experimental -spontaneous)/(total -spontaneous)] x 100. Viral stimulator cells were prepared by incubating spleen cells from normal mice with u.v.-inactivated HSV-1 (m.o.i. 2) for 2 h. Infected ceils were Xirradiated with 2400 rad. The lymphocyte proliferation assay was performed as previously described (Lathey et al., 1987) .
Statistical analysis. Each treatment group for DTH contained four to six mice. The mean differences in footpad swelling between the virus-challenged footpad and the opposite pad treated similarly with saline were analysed by the Student's t-test. The mean differences in footpad swelling among the treatment groups were analysed by a combined t-test (Swinscow, 1978) . (Fig. la) .
RESULTS
Inhibition of DTH induction by anti-id immunization
Intravenous or i.p. exposure to infectious HSV-1 is known to result in tolerance for the DTH response (Larsen et al., 1984; Nash, 1985) . To determine whether the same occurred in mice immunized with the anti-id reagents, animals in these and control groups (the latter received saline or preimmune rabbit IgG) were sensitized s.c. with infectious HSV-1 at the time of initial DTH testing. After a further 7 days, mice in all groups were retested for HSV-l-specific DTH. Whereas mice in groups that received anti-id D, saline or preimmune IgG became DTHpositive, mice given anti-id C or HSV-1 i.p. remained unresponsive (Fig. 1 b and c) . Mice in each of these latter groups remained DTH-negative for at least 5 months (data not shown). The failure to develop DTH was specific to HSV-I since significant DTH responses were observed in mice that received anti-id C or HSV-I i.p. and were subsequently sensitized with vaccinia virus and tested for vaccinia virus DTH 7 days later (Fig. 1 d) . These mice remained DTH tolerant for HSV-1 after vaccinia virus challenge (data not shown). 
Suppression of HSV DTH by adoptive transfer
To investigate further whether the state of DTH tolerance to HSV-1 induced by anti-id C immunization was similar to that which resulted from i.p. immunization with HSV-1, an adoptive spleen cell transfer approach was used to measure DTH suppression. In these experiments, mice in the various groups described in Fig. 1 were killed after immunization, HSV priming and DTH testing and their splenocytes were transferred to X-irradiated (150rad), syngeneic, naive mice. Recipient mice were primed in the ear 24 h later with HSV-1 and then tested for DTH by footpad injection of u.v.-irradiated HSV-1 after a further 2 weeks. As is shown in Fig. 2 , mice in all groups developed HSV-l-specific immediate hypersensitivity 
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reactions and mice in all but the anti-id C and anti-HSV (i.p.) immunized groups developed DTH responses when measured at 24, 48 and 72 h post-challenge, Thus, splenocytes from both anti-id C and HSV-1 tolerized mice prevented the DTH response in recipients sensitized with HSV-1. All donor mice used in this adoptive transfer had HSV-1 antibodies with titres of /> 16000 by ELISA (data not shown).
Phenotype of cells involved in HSV-1 DTH suppression
To elucidate further the cellular mechanism of suppression, splenocytes from mice that received anti-id C, HSV-1 (i.p.) or preimmune IgG were obtained and 0.9 splenic equivalents were either treated with anti-Thy 1.2 + C', anti-Ig + C', or were treated with C' alone. Treated cell populations were transferred to X-irradiated (150rad) recipients and the effects on subsequent sensitization with HSV-1 were assessed 7 days after virus priming. As before, splenocytes from mice immunized with preimmune IgG had no effect on the generation of a DTH response in recipients. Furthermore, whereas C'-treated and Ig + C'-treated splenocytes from anti-id C and HSV-1 (i.p.) immunized mice could suppress DTH, this effect was absent following treatment with anti-Thy 1.2 + C'. Thus, in both instances the suppression of DTH was mediated by a T cell (Fig. 3) .
To test whether the suppression of DTH was specific to HSV-1, mice unresponsive to HSV-1 were subsequently sensitized with either HSV-2 or vaccinia virus, then challenged with the appropriate virus. Mice in all groups developed DTH responses to the second virus, while being unresponsive to HSV-1 (Table 2) .
Split tolerance in anti-id C and HSV-1 DTH-suppressed mice
To determine whether the failure of mice adoptively transferred with anti-id C and HSV-1 tolerized splenocytes was restricted to the DTH response, selected mice were bled and killed 3 Fig. 3 which had received spleen cells treated with anti-Ig plus C'. t Mice were primed with 5 x 10 s p.f.u, of HSV-2 in the right pinna 2 weeks after HSV-1 challenge (Fig. 3) . Two weeks later, the right hind footpad was challenged with u.v.-inactivated HSV-2. Seven days later the left hind footpad was challenged with u.v.-inactivated HSV-1. All values are the mean difference + S.E.M. between the virus challenged and the saline-challenged footpad at 24 h post-challenge.
:~ Mean differences in footpad swelling of these groups were significantly lower than all other groups tested, P < 0.05 (combined t-test). Also, in contrast to all the other groups, the swelling seen in the left foot compared to the saline control foot was not significant at P < 0-05 (Student's t-test).
§ Mice were primed with 1 x 105 p.f.u, of vaccinia virus 7 days after HSV-I challenge, then challenged 7 days later with u.v.-inactivated vaccinia virus in the footpad. All values are the mean difference + S.~.M. between the virus-challenged and the saline-challenged footpad at 24 h post-challenge.
weeks after s.c. priming with HSV-I and subsequent DTH testing. Recipients of splenocytes from non-DTH-~tolerized mice were also investigated. Sera from all groups of mice contained specific anti-HSV-1 antibody (titres > 5500 by ELISA) and their splenocytes stimulated (5 days)
in vitro lysed HSV-1 infected target cells in a major histocompatibility complex restricted manner (Table 3) . Splenocytes from the same groups demonstrated antigen-specific * Two C3H/HeJ (H-2 k) mice from each C' only treatment group described in Fig. 3 were bled from the retroorbital sinus, sacrificed and their spleens removed 3 weeks after HSV-1 challenge. Mice receiving adoptively transferred cells at the same time demonstrated DTH tolerance during this period (Table 2) .
1" Data represent the mean + S.E.M. of three replicates. The L targets were L929 cells either uninfected (L cells) or infected with HSV-1 (HSV-1 L cells). The A targets were BALB/c 3T3 A31 cells infected with HSV-1 (HSV-1 A cells).
:~ Splenocytes were incubated in vitro with u.v.-inactivated HSV-1 or medium only. On the 5th day the cells were tested for [3H]TdR incorporation. Data represent the mean for t2 replicates +_ S.E.M., § Titre determined by a standard ELISA procedure. Plates were coated with an optimum dilution of HSV-Iinfected or -uninfected cells extracts. Titres were determined as the reciprocal of the dilution with an A49o of at least 0.1 and twice that of negative control values.
proliferation in response to HSV-1 stimulation (Table 3) . Consequently, the suppression induced by i.p. inoculation of HSV-1 or anti-id C was confined to the DTH resposne. DISCUSSION We demonstrate in this report that immunization of mice with a heterologous anti-idiotypic antibody to monoclonal anti-glycoprotein C selectively toierizes recipients for an HSV-l-specific DTH response. The effect mimics the split tolerance that occurs following i.v. or i.p. exposure of mice to infectious virus (Nash & Ashford, 1982; Schrier et al., 1983 ; Larsen et al., 1984) . Thus, in all cases the lack of responsiveness involves only DTH, and tolerized mice still produce antibody, express immediate hypersensitivity and their splenocytes generate antigen-specific CTL and lymphoproliferative responses upon stimulation in vitro. The suppressed DTH response was antigen-specific and mediated by T cells. Accordingly, suppression was transferrable with splenocytes and splenic T cells from anti-id C-immunized mice. Moreover, whereas recipients were incapable of mounting DTH responses following immunization with HSV-1, they could generate DTH responses after immunization with vaccinia virus and even cross-reacting HSV-2.
Although split tolerance following certain routes of immunization with viruses has repeatedly been demonstrated and shown to be mediated by suppressor cells (Leung et al., 1980; Nash & Ashford, 1982; Schrier et al., 1983) , a mechanistic explanation for the selective effect on DTH is not at hand. Some have suggested that split tolerance involves induction of idiotype-antiidiotype regulatory networks (Nash & Gell, 1981 ; Dorf & Benacerraf, 1984) . Our observation of split tolerance following immunization with an anti-id reagent is in accordance with this hypothesis. It could be that the anti-id we describe either elicits or acts passively as a component of the postulated regulatory network that prevents the development of DTH. Since the effect lasted for at least 5 months and was transferable with cells, the immunization seemingly plays an active role and induces antigen-specific regulatory cells. Such cells could directly inhibit DTH after subsequent exposure to a specific HSV-1 epitope, or stimulate a component of a DTH suppressor cell cascade. Alternatively, anti-id C could prime a T suppressor cell, initiating proliferation and factor production. This primed cell would then release suppressor factor only when activated by HSV-I antigen. There is evidence for the existence of a primed pre-T suppressor cell in the 4-hydroxy-3-nitrophenylacetyl (NP) system (Minami et al., 1983) .
The apparent failure of anti-id C to regulate other aspects of immunity requires explanation. It could be that the immune networks involved in humoral antibody and CTL induction are distinct and are controlled by different regulatory idiotopes. Accordingly, the selective effect on DTH by i.v. or i.p. exposure to virus could result from the preferential induction of suppressor cells directly by antigen or by subsets of antigen-presenting cells that differ functionally from those found in subcutaneous locations. Alternatively, networks involved in antibody and CTL induction may have auxiliary mechanisms that compensate for idiotope-specific suppression. This latter effect has been demonstrated for antibody production in the hapten system. For example, a normal anti-NP response can be observed in anti-id-suppressed mice, but none of the antibodies express the idiotopes recognized by the anti-id (Rajewsky & Takemori, 1983) . Further experiments are clearly needed to identify the mechanisms of suppression as well as to investigate whether anti-id C immunization can induce DTH tolerance when given by routes other than by the i.p. route.
Our observation of anti-id C-induced DTIt suppression was unexpected although it is not the first report of anti-id immunization inducing suppression of a DTH response. A well defined suppressor cell-mediated mechanism, active against DTH and induced by anti-id immunization, has been described in the anti-azobenzenearsonate (ABA) system (Monroe et al., 1985) . However, our findings represent the first in the virus field and are of interest since suppression was obtained against a highly complex set of antigens following exposure to antibody against a monoclonal antibody produced against only one of many glycoproteins found in the envelope of HSV-1. Elsewhere, we have described the spectrum of reactivity of the anti-id C reagent (Lathey et al., 1986) . Whereas it does detect idiotopes on monoclonal antibodies reactive with some other HSV glycoproteins, the idiotope was detectable on very few reagents and was neither detectable on other monoclonal antibodies to gC nor on polyclonal anti-HSV antibodies. Thus, the anti-id C apparently does not react with an immunodominant cross-reactive idiotope present on HSV antibodies. We must presume, however, that anti-id C recognizes a dominant idiotope of the HSV-1 immune network (but notably not that for HSV-2) that induces DTH suppression. Alternatively, the anti-id C may elicit suppressor cells which, upon activation by specific antigens, induce non-specific mechanisms that modulate DTH responses to other antigens, if the latter effect occurs, we might expect that whereas suppression of DTH induction is confined to HSV-1 if animals were simultaneously primed and challenged with HSV-2, or even vaccinia virus, at the same time as HSV-1 inoculation, then modulation of the DTH response to HSV-2 and vaccinia virus would also occur. Support for this latter idea comes from observations that the suppressor factor involved in anti-id-stimulated suppression of the ABA DTH response is not antigen-specific in its activity. However, the T suppressor cell that produces this factor has to be activated by ABA (Monroe et al., 1985) .
Anti-idiotypic antibodies have been advocated as alternatives to traditional vaccines (Fields & Greene, 1982; Reagan et al., 1983; Ertl & Finberg, 1984; Hay et at., 1984; Kennedy et aL, 1984b; GelI & Moss, 1985 ; Utydehaag & Osterhaus, 1985) but in viral systems have been so far without notable success. In our own investigations with anti-idiotypic reagents against monoclonal antibodies to HSV-I glycoproteins, we have observed only weak cellular responses and no measurable antibody following administration to mice in vivo (Lathey et al., 1986 (Lathey et al., , 1987 . Furthermore, anti-id-immunized mice were not more resistant to infection: one group has even observed the contrary result and noted that mice immunized with an antibody to an anti-HSV glycoprotein monoclonal antibody were more susceptible to infection (Kennedy et al., 1984a) . Our present observation of split tolerance following anti-id immunization suggests a clinical use for anti-ids in certain situations where the immune response plays an immunopathological role, as is often the case in herpesvirus infection (Rouse, 1984) . We are currently assessing models of HSV immunopathology to determine whether anti-id C immunization can favourably influence HSV pathogenesis.
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